Cosmos Health Inc.
COSMNASDAQHealthcare● Active
$0.23
$-0.02(-8.29%)
Market Cap$13790108
P/E Ratio—
52W High$1.32
52W Low$0.22
Cosmos Health Inc. (COSM) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
COSM · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 21, 2026EPS Actual
-$0.06
Est. -$0.06 · +0.0%
Revenue
$0.02B
Est. $0.02B · -0.2%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 21, 2026
After Market Close
✓ 1-Quarter EPS Beat Streak
COSM reports quarterly as a NASDAQ-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 17, 2026 | $0.01 | — | — | — | $0.02B | — |
| — Q2 FY2026 | May 21, 2026 | -$0.06 | -$0.06 | +0.0% | $0.02B | $0.02B | -0.2% |
| ▼ Q2 FY2026 | May 20, 2026 | -$0.01 | -$0.33 | -3200.0% | $0.02B | $0.02B | +4.7% |
| ▼ Q4 FY2025 | Nov 14, 2025 | -$0.01 | -$0.17 | -1600.0% | $0.02B | $0.02B | +4.3% |
| ▼ Q3 FY2025 | Aug 18, 2025 | $0.01 | -$0.06 | -700.0% | $0.01B | $0.02B | -15.6% |
| ▲ Q2 FY2025 | May 15, 2025 | -$0.03 | $0.01 | +133.3% | $0.01B | $0.02B | -11.5% |
| ▲ Q2 FY2025 | Apr 15, 2025 | -$0.09 | -$0.08 | +11.1% | $0.01B | $0.01B | -1.9% |
| ▼ Q4 FY2024 | Nov 14, 2024 | -$0.11 | -$0.45 | -309.1% | $0.01B | $0.01B | -14.4% |
Q3 FY2026
Aug 17, 2026
EPS Actual
—
EPS Est.
$0.01
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 21, 2026
EPS Actual
-$0.06
EPS Est.
-$0.06
EPS Surpr.
+0.0%
Revenue
$0.02B
Q2 FY2026
May 20, 2026Miss
EPS Actual
-$0.33
EPS Est.
-$0.01
EPS Surpr.
-3200.0%
Revenue
$0.02B
Q4 FY2025
Nov 14, 2025Miss
EPS Actual
-$0.17
EPS Est.
-$0.01
EPS Surpr.
-1600.0%
Revenue
$0.02B
Q3 FY2025
Aug 18, 2025Miss
EPS Actual
-$0.06
EPS Est.
$0.01
EPS Surpr.
-700.0%
Revenue
$0.01B
Q2 FY2025
May 15, 2025Beat
EPS Actual
$0.01
EPS Est.
-$0.03
EPS Surpr.
+133.3%
Revenue
$0.01B
Q2 FY2025
Apr 15, 2025Beat
EPS Actual
-$0.08
EPS Est.
-$0.09
EPS Surpr.
+11.1%
Revenue
$0.01B
Q4 FY2024
Nov 14, 2024Miss
EPS Actual
-$0.45
EPS Est.
-$0.11
EPS Surpr.
-309.1%
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.03 | $0.03 | $0.03 | 1 |
| Q3 FY2027 | $0.03 | $0.03 | $0.03 | 1 |
| Q2 FY2027 | $0.01 | $0.01 | $0.01 | 1 |
| Q1 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2026 | $0.04 | $0.04 | $0.04 | 1 |
| Q3 FY2026 | $0.02 | $0.02 | $0.02 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 21, 2026 | +0.0% | $0.28 | $0.26 | -10.20% |
| ▼ Q2 FY2026 | May 20, 2026 | -3200.0% | $0.28 | $0.28 | +0.64% |
| ▼ Q4 FY2025 | Nov 14, 2025 | -1600.0% | $0.73 | $0.72 | -0.69% |
| ▼ Q3 FY2025 | Aug 18, 2025 | -700.0% | $0.90 | $0.85 | -5.25% |
| ▲ Q2 FY2025 | May 15, 2025 | +133.3% | $0.45 | $0.45 | -0.22% |
| ▲ Q2 FY2025 | Apr 15, 2025 | +11.1% | $0.34 | $0.35 | +1.75% |
| ▼ Q4 FY2024 | Nov 14, 2024 | -309.1% | $0.70 | $0.65 | -6.04% |
| ▲ Q3 FY2024 | Aug 20, 2024 | +71.4% | $1.26 | $1.07 | -15.08% |
Q2 FY2026-10.20%
Report Date
May 21, 2026
EPS Beat/Miss
+0.0%
Price Before
$0.28
Price After
$0.26
Q2 FY2026+0.64%
Report Date
May 20, 2026
EPS Beat/Miss
-3200.0%
Price Before
$0.28
Price After
$0.28
Q4 FY2025-0.69%
Report Date
Nov 14, 2025
EPS Beat/Miss
-1600.0%
Price Before
$0.73
Price After
$0.72
Q3 FY2025-5.25%
Report Date
Aug 18, 2025
EPS Beat/Miss
-700.0%
Price Before
$0.90
Price After
$0.85
Q2 FY2025-0.22%
Report Date
May 15, 2025
EPS Beat/Miss
+133.3%
Price Before
$0.45
Price After
$0.45
Q2 FY2025+1.75%
Report Date
Apr 15, 2025
EPS Beat/Miss
+11.1%
Price Before
$0.34
Price After
$0.35
Q4 FY2024-6.04%
Report Date
Nov 14, 2024
EPS Beat/Miss
-309.1%
Price Before
$0.70
Price After
$0.65
Q3 FY2024-15.08%
Report Date
Aug 20, 2024
EPS Beat/Miss
+71.4%
Price Before
$1.26
Price After
$1.07
Avg Beat Reaction-5.94%
Avg Miss Reaction-2.83%
Beat Rate4 / 8 quarters
Largest Move-15.08% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: COSM ends December
Cosmos Health Inc. (COSM) most recently reported earnings on May 21, 2026 for Q2 FY2026, posting EPS of $-0.06 (in line with the analyst consensus of $-0.06). The next COSM earnings date is expected around September 1, 2026.
Each quarter, investors track COSM earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. COSM revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
COSM's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
COSM earnings · 4 questionsCosmos Health Inc.'s next earnings report is expected around September 1, 2026. COSM typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; COSM historically reports after market close (AMC).
COSM earnings datewhen is COSM earningsCOSM next earnings datewhen does COSM report earningsCOSM earnings calendar
▸ Source: FMP · Cosmos Health Inc. SEC filings · US GAAP · Cosmos Health Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026